Loading
A phase 2 trial of ES014 in desmoid tumour, run by Elpiscience (Suzhou) Biopharma, Ltd., now recruiting.
A Study in Adults With Desmoid Tumors is a phase 2 interventional study registered as NCT07541430 by Elpiscience (Suzhou) Biopharma, Ltd., with 50 participants planned, started 2026-04-30 and due to reach its primary completion in 2028-01. Interventions recorded: ES014.
Shares Desmoid tumour and the tag pipeline.